← Back to Search

Regenerative Injection Therapy

Regenerative Injection Therapy for Plantar Fibroma

Phase 4
Waitlist Available
Research Sponsored by Réseau de Santé Vitalité Health Network
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up every 3 weeks from week 0 to 36
Awards & highlights

Study Summary

The purpose of this study is to demonstrate that prolotherapy in conjunction with a physiotherapy program looking at reinforcing calf muscle and muscle of the plantar fascia, relieves pain and improves function of people suffering of plantar fasciitis, an inflammation of the plantar fascia, after basic treatment failure.

Eligible Conditions
  • Plantar Fibroma

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~every 3 weeks from week 0 to 36
This trial's timeline: 3 weeks for screening, Varies for treatment, and every 3 weeks from week 0 to 36 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Assessment of pain and function of the affected foot during the course of treatment
Secondary outcome measures
Assessment of pain intensity and pain-related function impairment during the course of treatment

Trial Design

3Treatment groups
Experimental Treatment
Active Control
Placebo Group
Group I: Regenerative Injection TherapyExperimental Treatment1 Intervention
Group II: ExerciseActive Control1 Intervention
Group III: Dry needlePlacebo Group1 Intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Regenerative injection therapy
2007
Completed Phase 4
~50

Find a Location

Who is running the clinical trial?

Réseau de Santé Vitalité Health NetworkLead Sponsor
8 Previous Clinical Trials
1,883 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~4 spots leftby Apr 2025